Cargando…

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

HER-2/neu gene amplification and cell surface overexpression are important factors in breast cancer for prognosis and prediction of sensitivity to anti-HER-2/neu monoclonal antibody therapy. In lung cancer, the clinical significance of HER-2/neu expression is currently under evaluation. We investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirsch, F R, Varella-Garcia, M, Franklin, W A, Veve, R, Chen, L, Helfrich, B, Zeng, C, Baron, A, Bunn, P A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375387/ https://www.ncbi.nlm.nih.gov/pubmed/11986780 http://dx.doi.org/10.1038/sj.bjc.6600286

Ejemplares similares

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003)

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003)

Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patients
por: Ady, N, et al.
Publicado: (2004)

Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer
por: Sagara, Y, et al.
Publicado: (2004)

Review of the Role of HER2/neu in Colorectal Carcinomas
por: Achalla, Lakshmi Sai Vijay, et al.
Publicado: (2022)

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients
por: Memon, A A, et al.
Publicado: (2004)

Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma
por: Mimura, K, et al.
Publicado: (2005)

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
por: Passalidou, E, et al.
Publicado: (2002)

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
por: Vicent, S, et al.
Publicado: (2004)

Nuclear survivin as a biomarker for non-small-cell lung cancer
por: Lu, B, et al.
Publicado: (2004)

Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells
por: Burchill, S A, et al.
Publicado: (2002)

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
por: Fontanini, G, et al.
Publicado: (2002)

Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis
por: Chen, I-H, et al.
Publicado: (2003)

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
por: Edwards, J, et al.
Publicado: (2003)

High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours
por: Lillington, D M, et al.
Publicado: (2002)

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients
por: Nakashima, T, et al.
Publicado: (2003)

Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer
por: Sardari Nia, P, et al.
Publicado: (2004)

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
por: Carlsson, J, et al.
Publicado: (2004)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis
por: Koukourakis, M I, et al.
Publicado: (2003)

Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours
por: Zurita, A J, et al.
Publicado: (2003)

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers
por: Dosaka-Akita, H, et al.
Publicado: (2002)

The tumour–stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
por: Masuya, D, et al.
Publicado: (2004)

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
por: Forrest, L M, et al.
Publicado: (2003)

Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer
por: Swinson, D E B, et al.
Publicado: (2004)

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas
por: Smith, S L, et al.
Publicado: (2004)

Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study
por: Qayoom, Sumaira, et al.
Publicado: (2023)

Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma
por: Kummar, S, et al.
Publicado: (2002)

Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells
por: Jin, X, et al.
Publicado: (2004)

Detection of replicative integrity in small colonic biopsies using the BrdUrd comet assay
por: McGlynn, A P, et al.
Publicado: (2003)

Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells
por: Shen, D-W, et al.
Publicado: (2004)

HER2/neu testing in primary colorectal carcinoma
por: Ingold Heppner, B, et al.
Publicado: (2014)

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
por: Pelosi, G, et al.
Publicado: (2003)

L523S, an RNA-binding protein as a potential therapeutic target for lung cancer
por: Wang, T, et al.
Publicado: (2003)

Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes
por: Papadakis, E D, et al.
Publicado: (2002)

Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers
por: Takimoto, M, et al.
Publicado: (2002)

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
por: Lantuejoul, S, et al.
Publicado: (2004)

Lung tumour markers in oncology practice: a study of TPA and CA125
por: Buccheri, G, et al.
Publicado: (2002)

Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis
por: Gong, Y, et al.
Publicado: (2002)

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma
por: Ueno, T, et al.
Publicado: (2003)

Suppressor of cytokine signalling gene expression is elevated in breast carcinoma
por: Raccurt, M, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_rheb4r7osl72ud2ln41qsrs1fd